Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxepin mouthwash for chemotherapy-induced oral mucositis in children
IRCT20230928059539N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in stomatitis comparing Doxepin mouthwash with Placebo (2 arms). Primary endpoint: Pain reported by patients. Started Nov 2023; status: completed.
02
Drugs
doxepin
03
Conditions
stomatitis
Beyond the preview
Go deeper on IRCT20230928059539N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230928059539N1.